FDA
-
-
-
-
-
-
-
Palvella Therapeutics Strengthens Leadership Team with Appointment of Rare Disease Commercial Leader Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services
-
-
-
-
-
-
-
Krystal Biotech (KRYS) PT Raised to $310 at Jefferies
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Krystal Biotech (KRYS)
-
-
-
-
-
-
-
Krystal Biotech Announces Update on Development Plans for Oncology Program KB707 and Prioritization of Inhaled KB707 for the Treatment of Non-Small Cell Lung Cancer
-
-
-
-
-
-
-
Krystal Biotech Announces First Patient Dosed in Phase 1/2 Trial of KB801 for the Treatment of Neurotrophic Keratitis
-
-
-
-
-
-
-
Krystal Biotech to Present at Upcoming Scientific Conferences
-
-
-
-
-
-
-
Krystal Biotech Announces Fourth Quarter and Full Year 2024 Financial and Operating Results
-
327,504 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

